We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.11B
AUM Growth
+$28.9M
Cap. Flow
-$70.4M
Cap. Flow %
-6.34%
Top 10 Hldgs %
20.71%
Holding
564
New
93
Increased
113
Reduced
193
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Financials 9.74%
3 Healthcare 8.27%
4 Industrials 8.16%
5 Consumer Discretionary 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$197B
$12.5M 1.12%
114,172
+21,356
+23% +$2.32M
HD icon
27
Home Depot
HD
$334B
$11.8M 1.07%
44,600
+620
+1% +$170K
LQD icon
28
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
$11.5M 1.04%
83,477
-10,175
-11% -$1.39M
XLK icon
29
State Street Technology Select Sector SPDR ETF
XLK
$119B
$11.5M 1.03%
176,166
-37,204
-17% -$2.27M
URI icon
30
United Rentals
URI
$65.8B
$10.6M 0.95%
45,637
+9,685
+27% +$2.05M
CAT icon
31
Caterpillar
CAT
$378B
$10.4M 0.94%
57,119
+3,799
+7% +$644K
VZ icon
32
Verizon
VZ
$208B
$10.2M 0.92%
173,557
-62,450
-26% -$3.71M
FDX icon
33
FedEx
FDX
$79.5B
$9.86M 0.89%
37,994
+974
+3% +$270K
XLC icon
34
State Street Communication Services Select Sector SPDR ETF
XLC
$22.7B
$9.62M 0.87%
142,575
+15,365
+12% +$978K
SHV icon
35
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$9.53M 0.86%
86,241
-7,338
-8% -$812K
AMZN icon
36
Amazon
AMZN
$2.81T
$9.28M 0.83%
56,960
+9,000
+19% +$1.44M
PGR icon
37
Progressive
PGR
$129B
$8.9M 0.8%
89,977
-202
-0.2% -$19.1K
VEU icon
38
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
$8.66M 0.78%
148,423
+71,763
+94% +$3.91M
AZN icon
39
AstraZeneca
AZN
$258B
$8.33M 0.75%
83,316
-6,329
-7% -$670K
ASML icon
40
ASML
ASML
$671B
$8.1M 0.73%
16,612
-86
-0.5% -$36.2K
CVX icon
41
Chevron
CVX
$393B
$8.01M 0.72%
94,868
-11,424
-11% -$925K
EQIX icon
42
Equinix
EQIX
$107B
$8.01M 0.72%
11,217
+3,892
+53% +$2.9M
AWK icon
43
American Water Works
AWK
$27.3B
$8M 0.72%
52,133
+22,084
+73% +$3.4M
META icon
44
Meta Platforms (Facebook)
META
$1.47T
$7.99M 0.72%
29,243
-5,684
-16% -$1.56M
HELE icon
45
Helen of Troy
HELE
$678M
$7.91M 0.71%
35,615
-787
-2% -$162K
ICVT icon
46
iShares Convertible Bond ETF
ICVT
$7.73B
$7.79M 0.7%
80,722
+12,572
+18% +$1.11M
GNRC icon
47
Generac Holdings
GNRC
$12.2B
$7.77M 0.7%
34,176
-15,375
-31% -$3.31M
NVDA icon
48
NVIDIA
NVDA
$5.08T
$7.62M 0.69%
583,400
+246,240
+73% +$3.3M
PYPL icon
49
PayPal
PYPL
$52.9B
$7.59M 0.68%
32,397
+11,310
+54% +$2.34M
NSIT icon
50
Insight Enterprises
NSIT
$4.45B
$7.53M 0.68%
98,999
+10,494
+12% +$707K

Similar funds

James Investment Research's Q4 2020 Portfolio in Review

As of Q4 2020, James Investment Research held 564 positions worth $1.11B, up 2.7% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

James Investment Research withdrew a net $70.4M in Q4 2020, closing 56 positions and reducing 193 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $4.67M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, James Investment Research opened a new position in Vanguard Morningstar Small-Cap Value ETF worth $15.4M.

  • James Investment Research's largest Q4 2020 buy was Vanguard Morningstar Small-Cap Value ETF: 108,050 shares worth $15.4M.
  • James Investment Research added most to iShares Russell 2000 Value ETF in Q4 2020, an estimated $15.2M increase.
  • James Investment Research's biggest Q4 2020 reduction was Microsoft, cutting an estimated $11.7M.
  • James Investment Research fully exited Regeneron Pharmaceuticals in Q4 2020, selling an estimated $4.67M.
  • James Investment Research's ten largest holdings make up 21% of its $1.11B portfolio in Q4 2020.
  • James Investment Research opened 93 new positions and closed 56 in Q4 2020.
  • James Investment Research's portfolio value rose 2.7% quarter-over-quarter to $1.11B.

Based on James Investment Research's 13F filing for Q4 2020, filed 27 Jan 2021.